Decreased plasma nesfatin-1 levels in patients with generalized anxiety disorder

Psychoneuroendocrinology

Volumn 37, Issue 12, 2012, Pages 1949-1953

  Gunay, Huseyin ^a   Tutuncu, Recep ^a   Aydin, Suleyman ^b   Dag, Ersel ^c   Abasli, Dilek ^a  

^a Etimesgut Military Hospital   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

^c KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

Generalized anxiety disorder; Plasma nesfatin 1; Satiety

Indexed keywords

NESFATIN 1; PEPTIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; GENERALIZED ANXIETY DISORDER; HUMAN; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; ANXIETY DISORDERS; CALCIUM-BINDING PROTEINS; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FASTING; HUMANS; MALE; NERVE TISSUE PROTEINS;

EID: 84869866502     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2012.04.007     Document Type: Article

References (38)

1. Ari M., Ozturk O.H., Bez Y., Oktar S., Erduran D. High plasma nesfatin-1 level in patients with major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:497-500.
2. Aslan M., Celik O., Celik N., Turkcuoglu I., Yilmaz E., Karaer A., Simsek Y., Celik E., Aydin S. Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus. Endocrine 2011, 2011 December 28 (Epub ahead of print AID). 10.1007/s12020-011-9577-8.
3. Atsuchi K., Asakawa A., Ushikai M., Ataka K., Tsai M., Koyama K., Sato Y., Kato I., Fujimiya M., Inui A. Centrally administered nesfatin-1 inhibits feeding behaviour and gastroduodenal motility in mice. Neuroreport 2010, 21:1008-1011.
4. Aydin S., Dag E., Ozkan Y., Erman F., Dagli A.F., Kilic N., Sahin I., Karatas F., Yoldas T., Barim A.O., Kendir Y. Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders. Mol. Cell Biochem. 2009, 328:49-56.
5. Bloem B., Xu L., Morava E., Faludi G., Palkovits M., Roubos E.W., Kozicz T. Sex-specific differences in the dynamics of cocaine- and amphetamine-regulated transcript and nesfatin-1 expressions in the midbrain of depressed suicide victims vs. controls. Neuropharmacology 2012, 62:297-303.
6. Bolton J.M., Cox B.J., Afifi T.O., Enns M.W., Bienvenu O.J., Sareen J. Anxiety disorders and risk for suicide attempts: findings from the Baltimore Epidemiologic Catchment area follow-up study. Depress Anxiety 2008, 25:477-481.
7. Caberlotto L., Fuxe K., Overstreet D.H., Gerrard P., Hurd Y.L. Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment. Brain Res. Mol. Brain Res. 1998, 59:58-65.
8. Dalman M.F., Akana S.F., Strack A.M., Hanson S., Sebastian R.J. The neural network that regulates energy balance is responsive to glucocorticoids and insulin and also regulates HPA axis responsivity at sites proximal to CRF neurons. Ann. N.Y. Acad. Sci. 1995, 771:730-742.
9. Demertzis K.H., Craske M.G. Anxiety in primary care. Curr. Psychiatry Rep. 2006, 8:291-297.
10. Deniz R., Gurates B., Aydin S., Celik H., Sahin İ., Baykus Y., Catak Z., Aksoy A., Citil C., Gungor S. Nesfatin-1 and other hormone alterations in polycystic ovary syndrome. Endocrine 2012, 2012 February 25 (a head of print AID). 10.1007/s12020-012-9638-7.
11. Domschke K., Dannlowski U., Hohoff C., Ohrmann P., Bauer J., Kugel H., Zwanzger P., Heindel W., Deckert J., Arolt V., Suslow T., Baune B.T. Neuropeptide Y (NPY) gene: impact on emotional processing and treatment response in anxious depression. Eur. Neuropsychopharmacol. 2010, 20:301-309.
12. Foo K.S., Brismar H., Broberger C. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience 2008, 156:563-579.
13. Goebel M., Stengel A., Wang L., Taché Y. Restraint stress activates nesfatin-1-immunoreactive brain nuclei in rats. Brain Res. 2009, 1300:114-124.
14. Gorman J.M. Anxiety disorders: introduction and overview. Comprehensive Textbook of Psychiatry 1999, 1441-1442. Lippincott Williams and Wilkins, Philadelphia. B.J. Sadock, V.A. Sadock (Eds.).
15. Heim C., Newport D.J., Mletzko T., Miller A.H., Nemeroff C.B. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 2008, 33:693-710.
16. Kohno D., Nakata M., Maejima Y., Shimizu H., Sedbazar U., Yoshida N., Dezaki K., Onaka T., Mori M., Yada T. Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology 2008, 149:1295-1301.
17. Könczöl K., Bodnár I., Zelena D., Pintér O., Papp R.S., Palkovits M., Nagy G.M., Tóth Z.E. Nesfatin-1/NUCB2 may participate in the activation of the hypothalamic-pituitary-adrenal axis in rats. Neurochem. Int. 2010, 57:189-197.
18. Kuperman Y., Issler O., Regev L., Musseri I., Navon I., Neufeld-Cohen A., Gil S., Chen A. Perifornical urocortin-3 mediates the link between stress-induced anxiety and energy homeostasis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:8393-8398.
19. Leal A.M., Moreira A.C. Food and the circadian activity of the hypothalamic-pituitary-adrenal axis. Braz. J. Med. Biol. Res. 1997, 30:1391-1405.
20. Li Q.C., Wang H.Y., Chen X., Guan H.Z., Jiang Z.Y. Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul. Pept. 2010, 159:72-77.
21. McLean C.P., Anderson E.R. Brave men and timid women? A review of the gender differences in fear and anxiety. Clin. Psychol. Rev. 2009, 29:496-505.
22. Merali Z., Cayer C., Kent P., Anisman H. Nesfatin-1 increases anxiety- and fear-related behaviors in the rat. Psychopharmacology (Berl.) 2008, 201:115-123.
23. Merali Z., McIntosh J., Kent P., Michaud D., Anisman H. Aversive and appetitive events evoke the release of corticotropinreleasing hormone and bombesin-like peptides at the central nucleus of the amygdala. J. Neurosci. 1998, 18:4758-4766.
24. Ogiso K., Asakawa A., Amitani H., Nakahara T., Ushikai M., Haruta I., Koyama K., Amitani M., Harada T., Yasuhara D., Inui A. Plasma nesfatin-1 concentrations in restricting-type anorexia nervosa. Peptides 2011, 32:150-153.
25. Oh-I.S., Shimizu H., Satoh T., Okada S., Adachi S., Inoue K., Eguchi H., Yamamoto M., Imaki T., Hashimoto K., Tsuchiya T., Monden T., Horiguchi K., Yamada M., Mori M. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006, 443:709-712.
26. Okere B., Xu L., Roubos E.W., Sonetti D., Kozicz T. Restraint stress alters the secretory activity of neurons co-expressing urocortin-1, cocaine- and amphetamine-regulated transcript peptide and nesfatin-1 in the mouse Edinger-Westphal nucleus. Brain Res. 2010, 1317:92-99.
27. Pecoraro N., Reyes F., Gomez F., Bhargava A., Dalman M.F. Chronic stress promotes palatable feeding, which reduces signs of stress: feedforward and feedback effects of chronic stress. Endocrinology 2004, 145:3754-3762.
28. Price C.J., Samson W.K., Ferguson A.V. Nesfatin-1 inhibits NPY neurons in the arcuate nucleus. Brain Res. 2008, 1230:99-106.
29. Ramanjaneya M., Chen J., Brown J.E., Tripathi G., Hallschmid M., Patel S., Kern W., Hillhouse E.W., Lehnert H., Tan B.K., Randeva H.S. Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology 2010, 151:3169-3180.
30. Rao T.L., Kokare D.M., Sarkar S., Khisti R.T., Chopde C.T., Subhedar N. GABAergic agents prevent alpha-melanocyte stimulating hormone induced anxiety and anorexia in rats. Pharmacol. Biochem. Behav. 2003, 76:417-423.
31. Rasic D., Robinson J.A., Bolton J., Bienvenu O.J., Sareen J. Longitudinal relationships of religious worship attendance and spirituality with major depression, anxiety disorders, and suicidal ideation and attempts: findings from the Baltimore epidemiologic catchment area study. J. Psychiatr. Res. 2011, 45:848-854.
32. Rotzinger S., Lovejoy D.A., Tan L.A. Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides 2010, 31:736-756.
33. Stengel A., Goebel M., Wang L., Rivier J., Kobelt P., Mönnikes H., Lambrecht N.W., Taché Y. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor 2 receptor. Endocrinology 2009, 150(November (11)):4911-4919.
34. Stengel A., Taché Y. Nesfatin-1 role as possible new potent regulator of food intake. Regul. Pept. 2010, 163:18-23.
35. Tannenbaum B.M., Brindley D.N., Tannenbaum G.S., Dalman M.F., McArthur M.D., Meaney M.J. High-fat feeding alters both basal and stress-induced hypothalamic-pituitary-adrenal activity in the rat. Am. J. Physiol. 1997, 273:1168-1177.
36. Ueta Y., Ozaki Y., Saito J., Onaka T. Involvement of novel feeding-related peptides in neuroendocrine response to stress. Exp. Biol. Med. 2003, 228:1168-1174.
37. Xu L., Bloem B., Gaszner B., Roubos E.W., Kozicz T. Stress-related changes in the activity of cocaine- and amphetamine-regulated transcript and nesfatin neurons in the midbrain non-preganglionic Edinger-Westphal nucleus in the rat. Neuroscience 2010, 170:478-488.
38. Zhang Z., Li L., Yang M., Liu H., Boden G., Yang G. Increased plasma levels of nesfatin-1 in patients with newly diagnosed type 2 diabetes mellitus. Exp. Clin. Endocrinol. Diabetes 2012, 120:91-95.